Please use this identifier to cite or link to this item:
https://doi.org/10.1186/bcr1861
Title: | ESR1 and EGF genetic variation in relation to breast cancer risk and survival | Authors: | Einarsdóttir, K Darabi, H Li, Y Low, Y.L Li, Y.Q Bonnard, C Sjölander, A Czene, K Wedrén, S Liu, E.T Hall, P Humphreys, K Liu, J |
Keywords: | epidermal growth factor ESR1 protein, human estrogen receptor alpha aged article breast tumor female genetics genotype haplotype human middle aged risk factor single nucleotide polymorphism survival Sweden Aged Breast Neoplasms Epidermal Growth Factor Estrogen Receptor alpha Female Genotype Haplotypes Humans Middle Aged Polymorphism, Single Nucleotide Risk Factors Survival Analysis Sweden |
Issue Date: | 2008 | Citation: | Einarsdóttir, K, Darabi, H, Li, Y, Low, Y.L, Li, Y.Q, Bonnard, C, Sjölander, A, Czene, K, Wedrén, S, Liu, E.T, Hall, P, Humphreys, K, Liu, J (2008). ESR1 and EGF genetic variation in relation to breast cancer risk and survival. Breast Cancer Research 10 (1) : R15. ScholarBank@NUS Repository. https://doi.org/10.1186/bcr1861 | Rights: | Attribution 4.0 International | Abstract: | Introduction: Oestrogen exposure is a central factor in the development of breast cancer. Oestrogen receptor alpha (ESR1) is the main mediator of oestrogen effect in breast epithelia and has also been shown to be activated by epidermal growth factor (EGF). We sought to determine if common genetic variation in the ESR1 and EGF genes affects breast cancer risk, tumour characteristics or breast cancer survival.Methods: We genotyped 157 single nucleotide polymorphisms (SNPs) in ESR1 and 54 SNPs in EGF in 92 Swedish controls and selected haplotype tagging SNPs (tagSNPs) that could predict both single SNP and haplotype variation in the genes with an R2of at least 0.8. The tagSNPs were genotyped in 1,590 breast cancer cases and 1,518 controls, and their association with breast cancer risk, tumour characteristics and survival were assessed using unconditional logistic regression models, Cox proportional hazard models and haplotype analysis.Results: The single tagSNP analysis did not reveal association evidence for breast cancer risk, tumour characteristics, or survival. A multi-locus analysis of five adjacent tagSNPs suggested a region in ESR1 (between rs3003925 and rs2144025) for association with breast cancer risk (p = 0.001), but the result did not withstand adjustment for multiple comparisons (p = 0.086). A similar region was also implicated by haplotype analyses, but its significance needs to be verified by follow-up analysis.Conclusion: Our results do not support a strong association between common variants in the ESR1 and EGF genes and breast cancer risk, tumour characteristics or survival. © 2008 Einarsdóttir et al.; licensee BioMed Central Ltd. | Source Title: | Breast Cancer Research | URI: | https://scholarbank.nus.edu.sg/handle/10635/183280 | ISSN: | 14655411 | DOI: | 10.1186/bcr1861 | Rights: | Attribution 4.0 International |
Appears in Collections: | Staff Publications Elements |
Show full item record
Files in This Item:
File | Description | Size | Format | Access Settings | Version | |
---|---|---|---|---|---|---|
10_1186_bcr1861.pdf | 555.84 kB | Adobe PDF | OPEN | None | View/Download |
This item is licensed under a Creative Commons License